Sensus Healthcare, Inc. 8-K

What Happened
Sensus Healthcare, Inc. (SRTS) filed an 8-K reporting the results of its Annual Meeting of Stockholders held May 29, 2026. Incumbents Eric Sachetta and Michael J. Sardano were re-elected as Class II directors for three-year terms expiring in 2029. Stockholders also approved, on a non-binding advisory basis, the 2025 executive compensation ("say-on-pay"), and ratified Carr, Riggs & Ingram, LLC as the company’s independent registered public accountant for the fiscal year ending December 31, 2026. Proxies were solicited under Regulation 14A and there was no opposing solicitation.

Key Details

• Director elections (Class II, terms to expire 2029):
  • Eric Sachetta — For: 5,532,247; Against: 516,567; Abstain: 270,440; Broker non-votes: 5,000,719.
  • Michael J. Sardano — For: 4,702,852; Against: 1,346,063; Abstain: 270,339; Broker non-votes: 5,000,719.
• Advisory vote on executive compensation (non-binding): For 4,740,572; Against 856,128; Abstain 722,554; Broker non-votes 5,000,719.
• Auditor ratification: Carr, Riggs & Ingram, LLC ratified as independent auditor — For 10,738,792; Against 148,466; Abstain 432,715.

Why It Matters
These votes confirm the company’s board composition and governance choices without changes to management or auditor. The re-election of two incumbent directors preserves board continuity; the approved non-binding say-on-pay indicates majority investor support for 2025 executive compensation policies; and the auditor ratification ensures the firm’s accounting firm is in place for fiscal 2026. Investors tracking governance, board stability, or auditor oversight can use these results as confirmation of shareholder backing on those topics.